Article thumbnail

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

By Robert S. Rosenson, Terry A. Jacobson, David Preiss, C. Stephen Djedjos, Ricardo Dent, Ian Bridges and Michael Miller
Publisher: Springer Nature
Year: 2016
DOI identifier: 10.1007/s10557-016-6666-1
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://link.springer.com/conte... (external link)
  • https://link.springer.com/cont... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.